CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Azelaic Acid

壬二酸 杂质对照品Azelaic Acid Impurities

27 个杂质条目27 impurity entries

本页汇总 壬二酸 的 27 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 27 impurity reference standards of Azelaic Acid. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 壬二酸(Azelaic Acid)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIdentification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS
    AAPS PharmSciTech · 2014 · Han S et al.  ·  PMID 24166667  ·  DOI
  2. 杂质研究Impurity studiesApplication of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation
    TheScientificWorldJournal · 2013 · Han S et al.  ·  PMID 24228008  ·  DOI
  3. 杂质研究Impurity studiesAnti-acne preparations containing tetracycline, azelaic acid and azeloglycine: Optimization of stability and physicochemical properties
    Polimery w medycynie · 2024 · Kostrzębska A, Szczepaniak G  ·  PMID 39625134  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of azelaic acid copolyester plasticizers and their application in PVC
    RSC advances · 2024 · Zhang W et al.  ·  PMID 39077328  ·  DOI
  • 合成方法SynthesisEfficient Enzymatic Synthesis of Lipophilic Phenolic Glycoside Azelaic Acid Esters and Their Depigmenting Activity
    Journal of agricultural and food chemistry · 2021 · Xu H et al.  ·  PMID 34705451  ·  DOI

壬二酸 —— 原料药与杂质对照品Azelaic Acid — drug substance & impurities

共 28 个条目(含原料药本体)28 items incl. the drug substance
Azelaic Acid structure
原料药 APIAPI
壬二酸Azelaic Acid
Azelaic Acid
CAS No.123-99-9
Chemical FormulaC9H16O4
Purity>95%询价On request
10mg25mg50mg100mg
(Z)-2-Nonenedioic Acid structure
—
(Z)-2-Nonenedioic Acid
CAS No.104360-82-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid 2-Ethylhexyl Monoester structure
—
壬二酸杂质2(壬二酸2-辛酯)Azelaic Acid 2-Ethylhexyl Monoester
Azelaic Acid 2-Ethylhexyl Monoester
CAS No.13050-58-3
Chemical FormulaC17H32O4
Purity>95%询价On request
10mg25mg50mg100mg
(E)-2-Nonenedioic Acid Dimethyl Ester structure
—
(E)-2-Nonenedioic Acid Dimethyl Ester
CAS No.13877-42-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Monoethyl Ester structure
—
壬二酸杂质1(壬二酸一乙基酯)Azelaic Acid Monoethyl Ester
Azelaic Acid Monoethyl Ester
CAS No.1593-55-1
Chemical FormulaC11H20O4
Purity>95%询价On request
10mg25mg50mg100mg
Dimethyl Azelate structure
—
壬二酸杂质7Dimethyl Azelate
Dimethyl Azelate
CAS No.1732-10-1
Chemical FormulaC11H20O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Monomethyl Ester structure
—
壬二酸杂质11Azelaic Acid Monomethyl Ester
Azelaic Acid Monomethyl Ester
CAS No.2104-19-0
Chemical FormulaC10H18O4
Purity>95%询价On request
10mg25mg50mg100mg
2-Nonenedioic Acid (Mixture of Z and E Isomers) structure
—
壬二酸杂质92-Nonenedioic Acid (Mixture of Z and E Isomers)
2-Nonenedioic Acid (Mixture of Z and E Isomers)
CAS No.72461-80-4
Chemical FormulaC9H14O4
Purity>95%询价On request
10mg25mg50mg100mg
(E)-2-Nonenedioic Acid structure
—
(E)-2-Nonenedioic Acid
CAS No.757219-33-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Nonanedioic acid 1-dodecyl ester structure
—
Nonanedioic acid 1-dodecyl ester
CAS No.94109-08-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Di(2-Ethylhexyl) Azelate-d14 structure
—
Di(2-Ethylhexyl) Azelate-d14
CAS No.—
Chemical FormulaC25H34D14O4
Purity>95%询价On request
Azelaic Acid 2-Ethylhexyl Monoester-d14 structure
—
Azelaic Acid 2-Ethylhexyl Monoester-d14
CAS No.—
Chemical FormulaC17H18D14O4
Purity>95%询价On request
Azelaic Acid Impurity 1 structure
1
壬二酸杂质1Azelaic Acid Impurity 1
Azelaic Acid Impurity 1
CAS No.—
Chemical FormulaC12H20O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 2 structure
2
壬二酸杂质2Azelaic Acid Impurity 2
Azelaic Acid Impurity 2
CAS No.—
Chemical FormulaC12H22O5
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 3(5-Oxoazelaic Acid) structure
3
壬二酸杂质3(5-氧代壬二酸)Azelaic Acid Impurity 3(5-Oxoazelaic Acid)
Azelaic Acid Impurity 3(5-Oxoazelaic Acid)
CAS No.57822-06-7
Chemical FormulaC9H14O5
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 3 structure
3
壬二酸杂质3Azelaic Acid Impurity 3
Azelaic Acid Impurity 3
CAS No.—
Chemical FormulaC15H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 4 structure
4
壬二酸杂质4Azelaic Acid Impurity 4
Azelaic Acid Impurity 4
CAS No.123-98-8
Chemical FormulaC9H14Cl2O2
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 5(Bis(2-ethylhexyl) Azelate) structure
5
壬二酸杂质5(壬二酸二(2-乙基己基)酯)Azelaic Acid Impurity 5(Bis(2-ethylhexyl) Azelate)
Azelaic Acid Impurity 5(Bis(2-ethylhexyl) Azelate)
CAS No.103-24-2
Chemical FormulaC25H48O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 6 structure
6
壬二酸杂质6Azelaic Acid Impurity 6
Azelaic Acid Impurity 6
CAS No.109-31-9
Chemical FormulaC21H40O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 8 structure
8
壬二酸杂质8Azelaic Acid Impurity 8
Azelaic Acid Impurity 8
CAS No.1931-63-1
Chemical FormulaC10H18O3
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 10 (Undecanedioic Acid) structure
10
壬二酸杂质10 (十一烷二酸)Azelaic Acid Impurity 10 (Undecanedioic Acid)
Azelaic Acid Impurity 10 (Undecanedioic Acid)
CAS No.1852-04-6
Chemical FormulaC11H20O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 12 structure
12
壬二酸杂质12Azelaic Acid Impurity 12
Azelaic Acid Impurity 12
CAS No.2374216-86-9
Chemical FormulaC14H24O6
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 14 structure
14
壬二酸杂质14Azelaic Acid Impurity 14
Azelaic Acid Impurity 14
CAS No.428-97-7
Chemical FormulaC9H14F2O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 15 structure
15
壬二酸杂质15Azelaic Acid Impurity 15
Azelaic Acid Impurity 15
CAS No.2064-80-4
Chemical FormulaC25H48O4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 16 (Mixture of E/Z-isomers) structure
16
壬二酸杂质16 (混合E/Z构型)Azelaic Acid Impurity 16 (Mixture of E/Z-isomers)
Azelaic Acid Impurity 16 (Mixture of E/Z-isomers)
CAS No.2575-01-1
Chemical FormulaC10H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 17 structure
17
壬二酸杂质17Azelaic Acid Impurity 17
Azelaic Acid Impurity 17
CAS No.242132-61-2
Chemical FormulaC11H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 19 structure
19
壬二酸杂质19Azelaic Acid Impurity 19
Azelaic Acid Impurity 19
CAS No.855957-40-3
Chemical FormulaC10H16O6
Purity>95%询价On request
10mg25mg50mg100mg
Azelaic Acid Impurity 20 structure
20
壬二酸杂质20Azelaic Acid Impurity 20
Azelaic Acid Impurity 20
CAS No.22399-98-0
Chemical FormulaC24H46O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

壬二酸 —— 研究文献与合成路线Azelaic Acid — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 壬二酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Azelaic Acid. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS
    Han S, Karłowicz-Bodalska K, Potaczek P, et al. · AAPS PharmSciTech · 2014 · 被引 7cited 7
  2. Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation
    Han S, Karlowicz-Bodalska K, Szura D, et al. · TheScientificWorldJournal · 2013 · 被引 5cited 5
  3. An innovative spectrofluorimetric approach for determination of azelaic acid in bulk and pharmaceutical formulation through derivatization with 9-chloromethylanthracene
    Abdel Hamid MA, Mabrouk MM, Hammad SF, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2022 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. A METHOD OF SYNTHESISING AN AMINO ACID DERIVATIVE OF AZELAIC ACID
    ZAINAB IDRIS, SALMIAH AHMAD, HAZIMAH ABU HASSAN, YEONG SHOOT KIAN, et al. · 公开号 WO2010117258WO2010117258 · 2010
  2. Preparation of azelaic acid by catalytic oxidizing system
    WU MANJIANG, GAO JUNJUN, ZHANG YAGANG, ZHANG YAGANG, et al. · 公开号 CN1680253CN1680253 · 2005
  3. Method for preparing azelaic acid by microwave reaction
    WUMANJIANG AILI, GAO JUNJUN, ZHANG YAGANG · 公开号 CN1616394CN1616394 · 2005
  4. Method for preparing azelaic acid by enzyme catalysis of hydrogen dioxide oxygenated oleic acid
    ELI WUMAIJIANG, NULEMAITI AYIXIAMUGULI, MAIMAITI XIAMUXIKAMARL, MAIMAITI HALIDAN · 公开号 CN101200735CN101200735 · 2008
  5. COSMETIC COMPOSITON CONTAINING AZELAIC ACID FOR TREATING ACNE SKIN AND ITS MANUFACTURING METHOD THEREOF
    KIM SANG JUN, KANG SE HHOON, HAN CHANG KYU, HAN SANG KEUN, et al. · 公开号 KR20080086229KR20080086229 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

壬二酸 杂质谱研究要点Azelaic Acid — impurity profiling notes

下面这些是拿到 壬二酸 的 28 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 28 impurity entries for Azelaic Acid, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances